文献速递前列腺增生与排尿功能障碍男科与性医学

与尿道萎缩相关的临床危险因素

Clinical Risk Factors Associated With Urethral Atrophy.
PubMed 文献 · Urology · 2016-12-16

该研究回顾性分析了2009年9月至2015年11月期间接受人工尿道括约肌(AUS)置入术的301例患者,排除60例(19.9%)经海绵体袖套患者后,对241例患者根据术中海绵体周径测量进行分组,比较尿道萎缩组(3.5 cm袖套)与对照组(≥4 cm袖套)的临床特征。结果显示,尿道萎缩与高龄、放疗史以及前列腺癌治疗至AUS手术的较长间隔时间相关;多因素分析中放疗是尿道萎缩的独立危险因素(OR 1.77,95%CI 1.01-3.13,P=0.046)。

要点

  • 尿道萎缩组患者年龄更大(71.1岁 vs 68.3岁,P<0.02)。
  • 尿道萎缩组放疗史比例更高(52.9% vs 33.3%,P<0.007)。
  • 前列腺癌治疗至AUS手术时间更长(8.9年 vs 6.6年,P<0.033)。

核心结论

  • 放疗史和前列腺癌治疗后时间延长与AUS置入前的尿道萎缩相关。

研究设计与样本

  • 回顾性分析2009年9月至2015年11月期间接受AUS置入术的301例患者,排除60例(19.9%)经海绵体袖套患者,最终分析241例。

主要发现

  • 在241例AUS患者中,尿道萎缩(3.5 cm袖套)151例(62.7%),较大袖套(范围4-5.5 cm)90例(37.3%)。
  • 尿道萎缩组与对照组比较:年龄71.1岁 vs 68.3岁(P<0.02);放疗史52.9% vs 33.3%(P<0.007);前列腺癌治疗至AUS手术时间8.9年 vs 6.6年(P<0.033)。
  • 多因素分析中,放疗与尿道萎缩风险独立相关(OR 1.77,95%CI 1.01-3.13,P=0.046)。
  • 癌症治疗与尿失禁手术之间较长时间接近临床显著性(OR 1.05,95%CI 1.00-1.09,P=0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze a series of clinical risk factors associated with pretreatment urethral atrophy. METHODS: We retrospectively reviewed 301 patients who underwent artificial urinary sphincter (AUS) placement between September 2009 and November 2015; of these, 60 (19.9%) transcorporal cuff patients were excluded. Patients were stratified into 2 groups based on intraoperative spongiosal circumference measurements. Men with urethral atrophy (3.5 cm cuff size) were compared to controls (≥4 cm cuff size). Chi-square test, Mann-Whitney U test, and logistic regression analyses were performed to determine risk factors for urethral atrophy. RESULTS: Among 241 AUS patients analyzed, urethral atrophy was present in 151 patients (62.7%) compared to 90 patients (37.3%) who received larger cuffs (range 4-5.5 cm). Patients with urethral atrophy were older (71.1years vs 68.3 years; P < .02), more likely to have received radiation (52.9% vs. 33.3%; P < .007), and had a longer time interval between prostate cancer treatment and AUS surgery (8.9 years vs. 6.6 years; P < .033). On multivariable analysis, radiation therapy was independently associated with risk of urethral atrophy (odds ratio 1.77, 95% confidence interval: 1.01-3.13; P = .046), whereas greater time between cancer therapy and incontinence surgery approached clinical significance (odds ratio 1.05, 95% confidence interval 1.00-1.09; P = .05). CONCLUSION: History of radiation therapy and increasing length of time from prostate cancer treatment are associated with urethral atrophy before AUS placement.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Viers BR, Mathur S, Hofer MD, et al. Clinical Risk Factors Associated With Urethral Atrophy. Urology. 2016. PMID: 27993713. doi:10.1016/j.urology.2016.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。